Peer-influenced content. Sources you trust. No registration required. This is HCN.

Pharmacy Practice NewsPrescribe Paxlovid, but Know the Risks

Despite sufficient resources available to help practitioners make the right decisions about prescribing nirmatrelvir-ritonavir to the patients who may benefit, there are, without a doubt, instances when not prescribing nirmatrelvir-ritonavir is completely justified.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form